Bracebridge Capital, LLC - CLARUS THERAPEUTICS HLDNGS I ownership

Back to all holdings Add to watchlist

CLARUS THERAPEUTICS HLDNGS I's ticker is and the CUSIP is 18271L107. A total of 25 filers reported holding CLARUS THERAPEUTICS HLDNGS I in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Bracebridge Capital, LLC ownership history of CLARUS THERAPEUTICS HLDNGS I
ValueSharesWeighting
Q2 2022$761,000
-74.5%
2,002,4950.0%0.12%
-45.5%
Q1 2022$2,984,000
-38.7%
2,002,4950.0%0.22%
-25.8%
Q4 2021$4,866,000
-54.4%
2,002,4950.0%0.30%
-68.3%
Q3 2021$10,673,000–2,002,495–0.94%–
 Download
Other shareholders

There were no reported owners of CLARUS THERAPEUTICS HLDNGS I in Q2 2022.

NameSharesValueWeighting ↓
View complete list of CLARUS THERAPEUTICS HLDNGS I shareholders